Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Lutetium
Every register, a page at a time. Strengths and packs are on each medicine’s page.
30 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lutetium | United States | Status unknown | |||
| Lutetium (177Lu) chloride Billev (previously Illuzyce) | European Union | Authorised | Billev Pharma Aps | ||
| Lutetium (177Lu) Chloride Radiopharmaceutical Precursor Solution 51.8 GBq/mL | Singapore | 51.8 GBq/mL | injection, solution (radiopharmaceutical) | Authorised | Transmedic Pte LTD |
| Lutetium (177Lu)-chloride Billev 51,8 GBq/ml radiofarmaceutische precursor, oplossing | Netherlands | Radiofarmaceutische uitgangsstof | Authorised | Billev Pharma ApS | |
| Lutetium [177Lu] chloride Billev | Croatia | Authorised | |||
| PituistatCombination | United States | Status unknown | |||
| Trace Mineral CordCombination | United States | Status unknown | |||
| EndolucinBeta | European Union | Authorised | ITM Medical Isotopes GmbH | ||
| Ilumira | European Union | Authorised | Shine Europe B.V. | ||
| Theralugand | European Union | Authorised | Eckert & Ziegler Radiopharma GmbH | ||
| Lutathera | United States | 177 DOTATATE 10mCi/ML | solution | Marketed | Aaa USA INC |
| Endolucinbeta Radiopharmaceutical Precursor Solution 40 GBQ/ML | Singapore | 40 GBq/ml | solution | Authorised | QT Instruments (S) Pte LTD |
| Pluvicto | United States | 177 VIPIVOTIDE TETRAXETAN 27mCi/ML | solution | Marketed | Novartis |
| Lumark | European Union | Withdrawn | I.D.B. Radiopharmacy B.V. | ||
| Lutathera | European Union | Authorised | Advanced Accelerator Applications | ||
| Lutathera | Italy | Soluzione per infusione | Authorised | Novartis Europharm Limited | |
| Lutathera | Canada | 370 MBq / ML | Solution | Marketed | Novartis Pharmaceuticals Canada INC |
| Lutathera 370 MBq/ml, oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | Novartis Europharm Limited | |
| Pluvicto | European Union | Authorised | Novartis Europharm Limited | ||
| Monlutenca 40 GBq/ml radiofarmaceutische precursor, oplossing | Netherlands | Radiofarmaceutische uitgangsstof | Authorised | Curium Romania SRL | |
| EndolucinBeta 40 GBq/mL, radiofarmaceutische precursor, oplossing | Netherlands | Radiofarmaceutische uitgangsstof | Authorised | ITM Medical Isotopes GmbH | |
| Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossing | Netherlands | Radiofarmaceutische uitgangsstof | Authorised | Shine Europe B.V. | |
| Pluvicto | Italy | Soluzione iniettabile o per infusione | Authorised | Novartis Europharm Limited | |
| Pluvicto 1.000 MBq/ml oplossing voor injectie/infusie | Netherlands | Oplossing voor injectie of infusie | Authorised | Novartis Europharm Limited | |
| Theralugand 40 GBq/ml radiofarmaceutische uitgangsstof, oplossing | Netherlands | Radiofarmaceutische uitgangsstof | Authorised | Eckert & Ziegler Radiopharma GmbH |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of EMA, FDA and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 3
- Medicines
- 10
- Companies
- 7